The Economics of Follow-on Drug Research and Development
- 1 January 2004
- journal article
- Published by Springer Nature in PharmacoEconomics
- Vol. 22 (Supplement) , 1-14
- https://doi.org/10.2165/00019053-200422002-00002
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- “Me-Too” Products — Friend or Foe?New England Journal of Medicine, 2004
- The Changing Structure Of The Pharmaceutical IndustryHealth Affairs, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- America's other drug problem: how the drug industry distorts medicine and politics.2002
- Health Insurance and the Growth in Pharmaceutical ExpendituresThe Journal of Law and Economics, 2002
- Risks in new drug development: Approval success rates for investigational drugsClinical Pharmacology & Therapeutics, 2001
- First‐Mover Advantage and the Speed of Competitive Entry, 1887–1986The Journal of Law and Economics, 2001
- New Drug Innovation and Pharmaceutical Industry Structure: Trends in the Output of Pharmaceutical FirmsDrug Information Journal, 2000
- The Pharmaceutical Industry — To Whom is It Accountable?New England Journal of Medicine, 2000
- Strategic Pricing of New PharmaceuticalsThe Review of Economics and Statistics, 1998